News
Exactech Announces Preliminary 2011 Sales of $205.4 Million and 4th Quarter 2011 Sales of $53.1 Million
GAINESVILLE, Fla. – January 31, 2012 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it expects to report revenue for the fourth quarter of 2011 of $53.1 million, an increase of 2.5% compared to $51.8 million for the fourth quarter of 2010 which will result in full year unaudited revenues of $205.4 million, compared to $190.5 million for 2010, an 8% increase. For the full year 2011, U.S. sales increased 1% to $133.0 million and international sales increased 24% to $72.4 million. During the fourth quarter, U.S. sales decreased 2% to $34.0 million and international sales increased 11% during the quarter to $19.1 million.
Exactech to Present to Investors at the 2012 Noble Financial Equity Conference on Jan 17
GAINESVILLE, Fla. – Jan. 9, 2012 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced that President David Petty and Chief Financial Officer Jody Phillips will present at the Eighth Annual Noble Financial Equity Conference in Hollywood, Florida on Tuesday, January 17th at 10:00 a.m. EST.
